OOIR: Observatory of International Research

Papers

(The H4-Index of Multiple Sclerosis and Related Disorders is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity	80
The nutritional risk in patients with neuromyelitis optica spectrum disorder	65
CNS resilience in the progression of MS	64
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination	57
Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022	56
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis	53
Chlamydia pneumonia infection and risk of multiple sclerosis: A meta-analysis	52
Role of serostatus in pediatric neuromyelitis optica spectrum disorders: A nationwide multicentric study	51
The effects of balance training on cognitive function in persons with multiple sclerosis: A systematic review and meta-analysis	48
Characteristics and predictors of sexual dysfunction in men with multiple sclerosis	47
Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study	46
The clinical and radiological features and prevalence of Neuro-Behçet's Disease: A retrospective cohort multicenter study in Saudi Arabia	44
Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder	43
OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool	42
Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients	40
Progressive post infectious neurological syndromes with a poor outcome: Long term follow-up and neurofilament light chain quantification	40
Spatio-Temporal Gait Parameters to Distinguish Multiple Sclerosis Disability during Dual- Task Walk	39
Clinical outcomes of partial sensory root rhizotomy on patients with recurrence of multiple sclerosing trigeminal neuralgia after percutaneous balloon compression	39
Utilizing the ISway to Identify and Compare Balance Domain Deficits in People with Multiple Sclerosis	38
The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia	37
Challenges of MS Patients for Receiving Health Care Services	37
Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden	37
Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany	36
Extended B-cell depletion beyond 6-months in patients receiving ocrelizumab or rituximab for CNS demyelinating disease	36
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)	36

Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study	35
Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes	34
How important are COVID-19 vaccine responses in patients with MS on disease-modifying therapies?	33
Effectiveness and safety of switching from fingolimod and natalizumab to rituximab in patients with relapsing remitting multiple sclerosis	33
Symptomatic trigeminal autonomic cephalalgias in neuromyelitis optica spectrum disorders	33
Effects of flexible scheduling and virtual visits on burnout for clinicians: 1- year follow-up	33
The presence of SARS-CoV2 antibodies in MS patients	32
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects	32
Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients	32
Infrequent patterns in cerebrospinal fluid isofocusing test: Clinical significance and contribution of IgG index and Reiber diagram to their interpretation	32